2026-10-25
Sensient Technologies clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 26,990 +1.35%
S&P 7,377 +0.31%
GOLD $4,075 −0.94%
BTC $75,727 −0.03%
VIX 25.64 −9.01%
latest tape · as of 18:05 UTC
The Screen · Basic Materials · Specialty Chemicals
Sensient Technologies Corporation
SXT · the NYSE · USD · Market cap $5.4B · 4,070 employees
Sensient Technologies Corporation, together with its subsidiaries, manufactures and markets colors, flavors, and other specialty ingredients worldwide.
Not yet scored119.19 USD
Price as of 6 Nov 2026Daily close, not a live quote
Screened 2026-11-06 · the tape above runs as of 18:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price119.19 USD at the 6 Nov 2026 close
- Our value readOvervalued vs our fair value, as of 6 Nov 2026
- Our regime readDistribution, as of 7 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans to puts (put/call 7.26)
- Last reviewed6 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: $93.34 to $107.35, base estimate $93.34 (screen dated 2026-11-06).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 7.26, read 2026-11-05
- Ethical screen not yet scored
Price119.19 USD
Fair value93.34
Ethical score70.0/100
Value readOvervaluedas of 6 Nov 2026
Our investment reviews on this name
2026-11-06Read Distribution119.75-0.5% to today ✓Accumulation gives way to Distribution after a 7% slide in 4 weeks
2026-10-11Read Accumulation128.42-7.2% to today Markdown gives way to Accumulation
2026-10-02Read Markdown128.42-7.2% to today ✓Accumulation gives way to Markdown
2026-09-14Read Accumulation128.60-7.3% to today Markup gives way to Accumulation while volume is distributing
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its distribution label.
Sensient Technologies Corporation holds its Distribution at $119.19. The statistical read favours the buyers, held for 1 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the buyers, held for 1 days |
| Price at the screen | $119.19 |
| Valuation | 31.69 trailing · 25.50 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 0.85 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 31.62% | Below 33% | Interest-bearing debt is just 31.6% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 15.24% | Below 49% | Money owed to the company is 15.2% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Sensient Technologies clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-07. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
Sensient Technologies clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 32%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 6 Nov 2026: it trades above our $93.34 fair value estimate, 10.60% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-06 screen. The gold marker is the market price at the same screen. The price runs 27.7% above the base estimate.
Third-party analyst targets: 5 covering, consensus Buy. The average target sits +22% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $93.34, with a range of $93.34 to $107.35, dated to the 2026-11-06 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsFlavours and colours maker priced for perfection
Walk into any supermarket and the bright hues in snacks or drinks often trace back to specialty chemical makers like Sensient. The business delivers solid 11% revenue growth and clears a 9% profit margin, yet our fair value sits at 89.37 dollars against a 109.05 dollar share price. That negative margin of safety rules out any opportunity, even though the ethical screen clears.
A forward multiple of 23 times earnings looks rich once the cyclical nature of specialty chemicals is factored in. Peak demand for flavours and extracts can flatten quickly when consumer spending slows, and a 12% return on equity offers little cushion if volumes turn. Analyst targets above 139 dollars ignore how low multiples at the top of a cycle often signal the start of mean reversion rather than a bargain.
Risks centre on raw material swings and customer concentration in food and beverage markets, both of which can compress margins faster than growth can offset. The absence of a clear moat leaves little protection when the cycle shifts. Analysis, not advice.
| Forward P/E | 25.5xexpensive even after accounting for its growth |
| Trailing P/E | 31.7xa premium valuation |
| EPS, trailing | 3.97 |
| EPS, forward | 4.93 |
| Revenue growth | +10.6%steady growth |
| Profit margin | 9.7%thin but positive margins |
| Return on equity | 13.7%a solid return on shareholder capital |
| FCF yield | -0.64% |
| Dividend yield | 132.00% |
| Debt to equity | 0.61moderate, manageable leverage |
| Current ratio | 3.97comfortably covers its short-term bills |
| Beta | 0.85steadier than the market |
| Short interest, float | 0.05% |
| 52-week range | 82.60 - 138.82 |
| Market cap | $5.4B |
| Employees | 4,070 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeSXT trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-06
Distribution · changed $119.75
-9.7% Entry 17
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 9.7% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (4 analysts) rates it buy, with a mean price target of $133.
2026-10-30
Accumulation $132.65
+0.0% Entry 16
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (4 analysts) rates it buy, with a mean price target of $133. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29
Accumulation $132.65
-1.9% Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.9% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (4 analysts) rates it buy, with a mean price target of $133. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28
Accumulation $135.22
+0.0% Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (4 analysts) rates it buy, with a mean price target of $133. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27
Accumulation $135.22
+0.0% Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (4 analysts) rates it buy, with a mean price target of $133. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26
Accumulation $135.22
+0.0% Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (4 analysts) rates it buy, with a mean price target of $133. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25
Accumulation $135.22
+0.0% Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 20% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (4 analysts) rates it buy, with a mean price target of $133. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24
Accumulation $135.22
+0.0% Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 20% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (4 analysts) rates it buy, with a mean price target of $133. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23
Accumulation $135.22
+1.3% Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 20% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (4 analysts) rates it buy, with a mean price target of $133. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18
Accumulation $133.42
+3.9% Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (4 analysts) rates it buy, with a mean price target of $133.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- What Sensient Technologies (SXT) Said on Its Q3 Earnings Call Yahoo Finance · 8d ago
- Sensient Technologies Corporation Q3 2026 Earnings Call Summary Yahoo Finance · 8d ago
- Sensient (SXT) Q3 2026 Earnings Call Transcript Yahoo Finance · 8d ago
- Sensient Sinks 12% as Revenue Miss and Unchanged Outlook Overshadow Earnings Beat Yahoo Finance · 8d ago
- Sensient Technologies (SXT) Beats Q3 Earnings and Revenue Estimates Yahoo Finance · 8d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
BCPCBalchem Corporation
EMNEastman Chemical Company
CLMTCalumet, Inc.
AXTAAxalta Coating Systems Ltd.
PRMPerimeter Solutions, Inc.
WLKWestlake Corp
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $117.33 | +2.0% | $0.41 | $1,024 | +2.4% |
| 2 months | $92.84 | +29.0% | $0.41 | $1,294 | +29.4% |
| 3 months | $91.31 | +31.1% | $0.41 | $1,316 | +31.6% |
| 6 months | $95.02 | +26.0% | $0.82 | $1,269 | +26.9% |
| 1 year | $94.92 | +26.1% | $1.64 | $1,279 | +27.9% |
| 2 years | $72.96 | +64.1% | $3.28 | $1,686 | +68.6% |
| 3 years | $70.98 | +68.7% | $4.92 | $1,756 | +75.6% |
| 5 years | $80.26 | +49.2% | $8.18 | $1,594 | +59.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever SXT does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.